Upload
cardiacanesthesia
View
14
Download
1
Embed Size (px)
DESCRIPTION
Sepsis Management in Adult ICU
Citation preview
PROPERTIESAllow user to leave interaction: AnytimeShow Next Slide Button: Show alwaysCompletion Button Label: View Presentation
Sepsis and Septic ShockOld Concepts, New Precepts
Babak Sarani, MDDivision of Traumatology and Surgical Critical
Care, Department of Surgery
University of Pennsylvania
Slide 3
Systemic Inflammatory Response Syndrome (SIRS)
Systemic inflammatory response to a variety of severe clinical insults. Manifested by two or more of the following:
Temperature >38C or 90 beats/min
Respiratory rate >20 breaths/min or PaCO2 12,000/mm3, 10% immature (band) forms
ACCP/SCCM Consensus Statement. Chest. 1992;101:1644-1655.
Slide 4
Sepsis: ACCP/SCCM Definitions Sepsis
Systemic response to infection i.e., confirmed or suspected infection plus 2 SIRS criteria
Severe Sepsis
Sepsis associated with organ dysfunction, hypoperfusion, or hypotension
Septic Shock
Severe Sepsis that cannot be resuscitated or stabilized with IV fluids aloneACCP/SCCM Consensus Statement. Chest. 1992;101:1644.
Slide 5
Sepsis - ACCP/SCCM Definitions: The Update
Altered mental status
Edema or increased fluid balance
Hyperglycemia (absent diabetes)
Increased CRP or procalcitonin
Hypotension
Increased SvO2
CI >3.5 L/min/m2
Arterial hypoxemia (PaO2/FiO2 2 hours)
Increased serum Cr (>0.5 mg/dL)
Coagulopathy (INR >1.5)
Ileus (absent bowel sounds)
Thrombocytopenia (40 mg/dLor 70 mmol/L)
Hyperlactatemia (>1 mmol/L)
Decreased capillary refill or mottling
Levy MM et al. Crit Care Med. 2003.
Slide 6
Septic Shock : ACCP/SCCM Definition
Sepsis-induced hypotension (despite adequate fluid resuscitation with the presence of perfusion abnormalities) may include, but are not limited to:
lactic acidosis
oliguria
acute alteration of mental status
Patients receiving inotropic or vasopressor agents may not be hypotensive at the time that perfusion abnormalities are measured.
ACCP/SCCM Consensus Statement. Chest. 1992;101:1644-55.
Slide 7
Martin GS et al. NEJM 2003;348:1346
Population Adjusted Incidence of Sepsis (USA)
Slide 8
Comparative Incidence and Mortality
Angus DC et al. Crit Care Med. 2001; 29:1303
0
50
100
150
200
250
300
AIDS Breast CA Prostate CA 1st MI Sepsis
Incidence
Cas
esX1
,000
0
50000
100000
150000
200000
250000
AIDS BreastCA
ProstateCA
AMI Sepss
Mortality
Dea
ths\
year
Slide 9
Martin GS et al. NEJM 2003;348:1346
Hospital Mortality Rate of Patients with Sepsis in the USA
Slide 10
Martin GS et al. NEJM 2003;348:1346
Cases of Sepsis by Pathogen (USA)
Slide 11
Infection Source in Severe Sepsis
44.0%
17.3%9.1%
8.6%
6.6%
2.2%
8.0%
6.0%
10.8%RespiratoryBacteremiaGUAbdomenSoft tissueDeviceCNSEndocarditisOther
Angus DC et al. Crit Care Med. 2001; 29:1303
Slide 12Martin GS et al. NEJM 2003;348:1346
Characteristics of Patients with Sepsis
Slide 13
Organ Failure and Associated Mortality with Severe Sepsis
Organ Failure Occurrence, % Mortality, %
One 73.6 21.2
Two 20.7 44.3
Three 4.7 64.5
Four 1.0 76.2
Respiratory 45.8 40.1
Cardiovascular 24.4 32.4
Renal 22.0 38.2
Hematologic 20.6 22.8
Central nervous system 9.3 24.4
Hepatic 1.3 54.3
Angus DC et al. Crit Care Med. 2001; 29:1303
Slide 14
Determinants of Mortality Source control is most vital factor
Resuscitation/re-establish perfusion in 6 hrs
Appropriate antibiotic therapy within 1 hr of hypotension
Slide 15
ACCP/SCCM Consensus Statement. Chest. 1992;101:1644-55.
Relationship of SIRS, Sepsis, and Infection
Slide 16
Van der Poll T, van Deventer SJH. Infect Dis Clin North Am.
Dynamic Nature of Sepsis
Slide 17
Hemodynamic Effects of Putative Septic Shock Mediators
Putative
Mediator
Arterial
Pressure
Cardiac
Output
Systemic
Vascular
Resistance
Ejection
Fraction
Miscellaneous
Effects
Endotoxin Decreased
(human, canine)
Increased
(human, canine)
Decreased
(human, canine)
Decreased
(human, canine)
WBC, pyrexia TNF, IL-1, IL-6
TNF Decreased(human, canine)
Increased
(human, canine)
Decreased
(human, canine)
Decreased
(canine)
Lactic acidosis,
pulmonary edema,
WBC, pyrexiaDIC, platelets
IL-1 Decreased(human, canine)
Increased
(human, canine)
Decreased
(human, canine)
Decreased
(canine)
Pyrexia,
platelets
IL-6No change
(canine)
No change
(canine)
No change
(canine)?
Hepatic acute phase
response
Kumar et al. J Cardiothorac Vasc Anesth. 2001.
Slide 18
Pathophysiology Distributive shock state
Vasodilation of arterioles low SVR, low BP nitric oxide (endothelium is the culprit!)
Compensate with tachycardia and elevated CO/CI
Pre-capillary A-V shunts Low BP bypass capillary resistance beds
Elevated SVO2 Elevated lactate
Slide 19
Metabolic Derangements in Sepsis
Elevated Lactate and MVO2:
Micro-anatomic shunts (non-nutrient capillaries)
Functional shunts (impaired microcirculatory vasomotor control)
Citric acid (Krebs) cycle defect with anaerobic glycolysis
Aerobic glycolysis with lactate production
Slide 20
Vasculature- Vasodilation- Vasoconstriction- Leukocyte Aggregation- Endothelial Cell Dysfunction
Cellular Dysfunction
Organs- Dysfunction- Metabolic Abnormalities
Myocardium- Depression- Dilatation
Shock
Refractory HypotensionMultiple Organ DysfunctionRecovery
Death
Nucleus
LysosomeMitochondria Actin/Myosin
Membranechannel
Membranereceptor
Pathogenesis of Septic Shock
Slide 21Waage A, Halstensen A, Espevick T. Lancet. 1987.
Serum Concentrations in Survivors and Nonsurvivorsof Septic Shock
150,000
TNF
units
/mL
seru
m
10
400600
1,0001,200
Serum from patientswho died
Serum from patientswho survived
Detection limitfor TNF
100,0001,400
1,000
200
Tumor Necrosis Factor (TNF)
Slide 22
Pathogen
Inflammation Coagulation
Monocyte
Tissue FactorCytokines
Pathophysiology of Sepsis
Slide 23
Coagulation CascadeSteps in
coagulationCoagulation
cascade
Initiation TF/VIIa
Propagation VIIIa
Thrombin activity
Fibrinogen Fibrin
IXa
IXX
Xa
IIVa
IIa
II indicates prothrombin; IIa, thrombin;IX, factor IX; IXa, activated factor IX; TF, tissue factor; Va, activated factor V; VIIa, activated factor VII; VIIIa, activated factor VIII; X, factor X; Xa, activated factor X.
Weitz JI et al. Chest. 2001.
Slide 24
Coagulation in Sepsis
Bernard GR et al. N Engl J Med. 2001;344:699-709.
Inflammatory Responseto Infection
Thrombotic Responseto Infection
Fibrinolytic Responseto Infection
Endothelium
TAFI
PAI-1
Suppressedfibrinolysis
Neutrophil
Monocyte
IL-6IL-1TNF
Bacterial, viral, fungal or parasitic infection/endotoxin
Bacterial, viral, fungal or parasitic infection/endotoxin
IL-6
Tissue Factor
Tissue Factor
COAGULATION CASCADE
Factor Va
Factor VIIIa
THROMBIN
FibrinFibrin clot
Slide 25
Pathogenesis of Sepsis
Slide 26
Protein C Levels Decrease Before Diagnosis of Severe Sepsis
Mesters et al. Crit Care Med. 2000;28:2209-2216.
PC HEM
20
40
60
80
100
120
WBCFever
6 hr12 hr
18 hr24 hr
36 hr48 hr
60 hr72 hr
PC A
ntig
en (%
)
Severe Sepsis Patients
Septic Shock Patients
Average Time to Diagnose Severe Sepsis
Slide 27
Septic Shock The Spiral
Slide 28
Sepsis: Hemostatic Imbalance
Slide 29
GTP cGMP
BloodBlood EndotheliumEndothelium SmoothMuscle
SmoothMuscle
GTPGTP
cGMPcGMP
GC
L-ArgL-ArgO2O2
L-citrullineL-citrulline
GCGCNONO..
cNOSPlateletsPlatelets
Nitric Oxide in the Vasculature
Slide 30
GTP cGMP
BloodBlood EndotheliumEndothelium SmoothMuscle
SmoothMuscle
GTPGTP
cGMPcGMP
GC
L-ArgL-ArgO2O2
L-citrullineL-citrullineGCGC
NONO
iNOSPlateletsPlatelets
iNOS
cNOS
EndotoxinCytokinesEndotoxinCytokines
NONO
Nitric Oxide in Sepsis
Slide 31
Septic Shock Hemodynamics Warm (hyperdynamic) shock
hypotensive
tachycardia
tachypnea
bounding pulse
warm, well-perfusedextremities
skin flushed, moist
Cold (hypodynamic) shock
hypotensive
tachycardia
tachypnea
narrow, thready pulse
cold, poorly perfusedextremities
skin pale, dry
Slide 32
Dilemmas in Diagnosing the Septic Patient
Combine clinical exam and labs/imaging
Physical exam alone is NOT adequate
Elderly Cant mount a fever or leukocytosis
Ability to develop bandemia preserved
Immunosuppressed/steroids
Slide 33
Diagnosing Sepsis Lab tests: CBC, Chemistry, Cultures, lactate, SVO2
SVO2 is a measure of O2 extraction (NL 70%) UNDER-RESUSCITATED septic pts have a LOW SVO2 RESUSCITATED septic pts have a HIGH SVO2
Lactate is a measure of the severity of sepsis Lactate > 4 that does not correct in 6 hrs correlates with
mortality
Slide 34
Hemodynamics in sepsis Lactate
Weil & Afifi, Circulation 1970.
Slide 35
Septic Shock Hemodynamics CVP does not accurately estimate ventricular filling
pressures in the critically ill.
When PCWP (PAOP) is appropriately elevated with resuscitation, 90% of patients with septic shock exhibit a hyperdynamic circulatory state.
Hyperdynamic state persists to death.
Slide 36
Car
diac
Inde
x (L
/min
/m2)
Time (days)
Parker et al. Ann Intern Med. 1984
1
0
2
5
6
3
4
1 2 4 7 10 1 2 4 7 10
7
SurvivorsNonsurvivorsAll Patients
Cardiac Index in Septic Shock (post-1980)
Slide 37
Hypovolemia in Septic Shock Causes:
Venous pooling
Interstitial third-spacing
w Insensible losses (fever, RR) w Oral intake
Slide 38
Septic Shock Hemodynamics Hypodynamic septic shock in humans = inadequately
fluid-resuscitated septic shock
Slide 39Mizock BA. Crit Care Med. 1992;20:80-93.
Oxy
gen
Con
sum
ptio
n
Oxygen Delivery
Critical DeliveryThreshold
Lacti
c Acid
osis
Physiologic Oxygen SupplyPhysiologic oxygen supply dependency indicating a critical delivery threshold below which lactic acidosis ensues
Slide 40
Mizock BA. Crit Care Med. 1992;20:80-93.
Oxy
gen
Con
sum
ptio
n
Oxygen Delivery
Pathologic
Physiologic
Oxygen Delivery and Consumption
The relationship between oxygen delivery and consumption under physiologic and pathologic conditions is demonstrated on this chart.
Slide 41
Capillary
Vascular Abnormality
Arteriole
NeutrophilAggregation
VasoconstrictionVasodilation
Endothelial CellDestruction
Venule
Cell
Pathogenesis of Septic Shock
Slide 42
Treatment of Septic Shock Source Control When Possible
Based on Early Goal Directed Therapy
Broad, high dose, rapid administration of antibiotics
Consider Activated Protein C
Minimal role for steroidsSurviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2008. Critical Care Med
Slide 43
16% absolute reduction in mortality
Rivers, NEJM 2001; 345:1368
Cultures
Slide 44
Treatment - Fluids Endpoints of therapy
MAP > 65 mm Hg, HR < 100 bpm
UOP > 0.5 cc/kg/hr
SVO2 70% or more
CVP > 10-15 mm Hg Higher if known cardiomegaly or intubated
TTE showing cardiac filling
Until you no longer see improvement in hemodynamics following boluses
Slide 45
Failure to Intervene
Sebat CCM 2007; 35: 2568
Slide 46
Treatment - Steroids Recommended only for shock refractory to pressors *Multicenter, European, RCT
Pts with vasopressor-resistant hypotension Improved mortality if rise in cortisol following ACTH was < 9mcg/dL
and if baseline cortisol < 21 mcg/dL **CORTICUS larger, European, RCT
All pts with septic shock (regardless of vasopressor response) No difference in mortality but vasopressor sparing effect with
steroids ACTH stimulation could not predict who had endogenous cortisol
deficiency
*JAMA 2002; 288:862
**NEJM 2008; 358:111
Slide 47
Hemodynamics in sepsisDeterminants of oxygen delivery (DO2)
DO2
Cardiac output
Oxygen content
Heart rateStroke volume
Hemoglobin
PaO2
O2 Sat %
Slide 48
Failure to Intervene
Sebat CCM 35: 2568; 2007
Slide 49
Treatment
Slide 50
Treatment - Drotrecogin Alfa Protein C levels decrease before the onset of signs of
septic shock and are associated with worsened mortality
Activated protein C
Anticoagulant (inhibits Factors V and VIII) Stop microthrombi formation and prevent end-organ loss?
Endothelial cell stabilizer (anti-inflammatory) Stop excessive production of cytokines and apoptosis?
Slide 51
Treatment - Drotrecogin Alfa PROWESS RCT, 1690 pts, stopped early
532 surgical pts
6% decrease in mortality overall Greatest decrease if APACHE II score > 25
1.5% increase in risk of bleeding Equal between medical and surgical groups
Bernard. NEJM 2001; 344:699
Case StudyThe following are case studies that can be used for review of this presentation.
Review Cases
Skip
Slide 53
Patient Presentation 45 year old male, fall down steps
No LOC
Arrives with c/o severe left hip/buttock pain
Slide 54
History PMH: None
PSH: None
Med: None
Allergy: None
Social: Occasional EtOH only
Travel: None
Slide 55
PE P 105 BP 110/55 RR 20 T 99.7
A&O with left hip/buttock pain, GCS = 15
Salient Findings:
Pelvis stable, intact grossly
Left buttock tensely swollen
LLE neurovascularly intact, no deformity
Perineal / Rectal exam normal
Slide 56
X-rays
Slide 57
X-rays
Slide 58
Scan
Slide 59
Labs WBC 19
Hg 11
Plt 171
Na 136; Cl 104; HCO3 12; BUN 42, Cr 4.2
Lactate 5.4 to 6.4
SVO2 39%
Slide 60
Hospital Course Pt talking on phone to wife regarding need for operation
Slide 61
Hospital Course Resuscitate, antibiotics
Co-oximeter catheter inserted, vasopressors
Endpoints: UOP, BP, CVP, lactate, SVO2 OR for serial debridements
Discharged to home with VAC dressings
Conclusion Tenets of Septic Shock and its Resuscitation
Source control is imperative
Broad spectrum, high dose, emperic antibiotics pending culture results
Resuscitate to established endpoints of perfusion and avoid excess fluid administration
Mixed venous oxygen saturation
Biochemical markers (lactate)
Echocardiogram to establish ideal CVP or L atrial pressure
Urine output
Mental StatusSlide 62
Self AssessmentReady to test your knowledge?
Take the Review
Skip the Review
PROPERTIESOn passing, 'Finish' button: Goes to Next SlideOn failing, 'Finish' button: Goes to Next SlideAllow user to leave quiz: At any timeUser may view slides after quiz: At any timeUser may attempt quiz: Unlimited times
Slide 65
References Martin GS, Mannino GM, Eaton S, et al. NEJM 2003;348:1546-54.
Angus DC, Linde-Zwirble WT, Lidicker J, et al. Crit Care Med 2001;29:1303-1310.
Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet. 2005;365:63-78.
Aird WC. Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis. Crit Care Med. 2001;29:S28-S34.
Kumar A, Haery C, Parrillo JE. Myocardial dysfunction in septic shock. Crit Care Clin. 2000;16:251-287.
Levy MM, Fink MP, Marsahll JC, et al. Crit Care Med 2003;31:1250-1256